Kangji Medical (HKG:9997) cleared a key hurdle in its HK$9.25-per-share privatization after the Grand Court of the Cayman Islands sanctioned the scheme of arrangement by Knight Bidco, according to a Tuesday joint Hong Kong bourse filing.
The scheme is expected to become effective on Dec. 5, once the sanction order is registered with the Cayman registrar.
Kangji's shares will be withdrawn from listing on Dec. 9, the filing showed.
Upon completion, Kangji will become a wholly owned subsidiary of Knight Bidco.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.